Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.13 USD | -0.13% | -0.68% | +7.87% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.87% | 3.43B | |
+13.31% | 128B | |
-9.13% | 10.9B | |
-2.59% | 8.69B | |
+37.50% | 5.48B | |
-22.36% | 4.72B | |
-11.25% | 2.76B | |
-14.85% | 2.05B | |
-13.29% | 1.93B | |
-28.75% | 1.67B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Earnings Flash (AXNX) AXONICS Reports Q1 Revenue $91.4M